Open AccessMetyrapone as Additive Treatment in Major Depression
Author(s) -
Holger Jahn,
Mildred Schick,
Falk Kiefer,
Michael Kellner,
Alexander Yassouridis,
Klaus Wiedemann
Publication year - 2004
Publication title -
archives of general psychiatry
Language(s) - English
Resource type - Journals
eISSN - 1538-3636
pISSN - 0003-990X
DOI - 10.1001/archpsyc.61.12.1235
Subject(s) - nefazodone , hamilton rating scale for depression , metyrapone , placebo , randomized controlled trial , depression (economics) , medicine , rating scale , fluvoxamine , psychology , anesthesia , major depressive disorder , serotonin , fluoxetine , developmental psychology , receptor , alternative medicine , pathology , amygdala , economics , macroeconomics
Inhibitors of steroid synthesis have been reported to exert antidepressive effects, according to preliminary findings.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom